Evidence map›Paper›PMID 33223215›Full record

ArticleJournal of hepatology2021

NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues.

Kamran Mushtaq, Muhammad Umair Khan, Fatima Iqbal, Deema Hussam Alsoub, Hammad Shabir Chaudhry, Fateen Ata, Phool Iqbal, Khaled Elfert, Girisha Balaraju, Muna Almaslamani and 3 more

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 5 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 5 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. COVID-19 and Fatty Liver Disorders.Journal of clinical medicine · 2023
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. COVID-19 and liver injury: An ongoing challenge.World journal of gastroenterology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Kamran MushtaqDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation; Harvard T.H Chan School of Public Health, USA. Electronic address: kmushtaq@hamad.qa.
Muhammad Umair KhanDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation; Harvard T.H Chan School of Public Health, USA.
Fatima IqbalHarvard T.H Chan School of Public Health, USA; Department of Infectious Disease, Communicable Disease Center, Doha, Qatar.
Deema Hussam AlsoubDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Hammad Shabir ChaudhryDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Fateen AtaDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Phool IqbalDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Khaled ElfertDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation.
Girisha BalarajuDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation.
Muna AlmaslamaniDepartment of Infectious Disease, Communicable Disease Center, Doha, Qatar; Weill Cornell Medicine, Qatar (WCM-Q), Doha, Qatar.
Khalid Al-EjjiDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation.
Saad AlKaabiDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation.
Yasser Medhat KamelDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation.
Hamad Medical Corporation · QAHarvard University · USCenter for Disease Dynamics, Economics & Policy · USWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Non-alcoholic Fatty Liver DiseaseHumansRetrospective StudiesSARS-CoV-2Severity of Illness IndexCOVID-19Fatty liverLiver injuryMAFLDMortalityNAFLD

Identifiers

PMID33223215
PMCPMC7836329
OpenAlexW3099890201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.